This story was first published in digitalhealth.net
New treatment for kidney cancer patients
People with advanced kidney cancer are to benefit from a new treatment that NICE has recommended.
The National Institute for Health and Care Excellence (NICE) recommends cabozantinib as an option for people with advanced renal cell carcinoma (RCC).
NICE was unable to recommend the drug following its initial assessment in February 2017. This is because it felt some of the clinical evidence presented by the company was unreliable.
In response to this, the company revised their submission to strengthen the evidence, and the NICE committee have since concluded that the drug is a cost-effective, viable treatment option for sufferers.
Since the tumour spreads to other parts of the kidney in the advanced stages of RCC, cabozantinib inhibits the growth of new blood vessels within a tumour and prevents it from spreading.
Carole Longson, Director of the Centre for Health Technology Evaluation at NICE said: “There are limited treatment options available for people who have advanced kidney cancer, so I am very pleased that the new evidence submitted means we can recommend cabozantinib.”
Latest News
16/02/2024 - 12:56
Hammersmith and Fulham Council has created a new alliance intended to clean dirty air and improve residents' health.
16/02/2024 - 10:44
Two million more GP appointments a month are being delivered for patients compared to the same month before the pandemic as part of the NHS primary care access recovery plan according to new NHS data.
15/02/2024 - 10:26
The Welsh Government has provided innovation funding of £380,000 to support two projects utilising technology in domiciliary care.
15/02/2024 - 10:13
The new Scottish health secretary has met with frontline staff at Queen Elizabeth University Hospital in Glasgow.
14/02/2024 - 10:27
The North East London NHS Foundation Trust (NELFT) has appointed three new Executive Directors to the Trust Board.
Product Features
UK Building Regulations highlight toxic gas and smoke from layers of paint built up over multiple redecorations as a major cause of permanent ill health or death in a building fire.
Their concern rose with discovery the flame retardant paints most widely used paint along escape routes have been ones which to this day counter-productively use emission of heavy toxic gas to smother flames which rapidly spread along walls if layers of paint delaminate in a fire.
Supplier Profiles
Northwich’s Victoria Infirmary (VIN) Community Diagnostic Centre (CDC) has enabled more patients
Adveco, the commercial hot water specialist, announces the launch of live metering of domestic ho
Latest Features
Sarah Greenslade, public affairs and communications officer at the British Parking Association looks at some of the problems and innovations in healthcare parking
It’s easy to assume that the comms team is there to handle press enquiries and the occasional social media storm – but the reality is that strategic communications can make a measurable impact across the entire organisation, from operational to financial, when done properly
